Cargando…
2025 Targeting immunosuppressive myeloid cells to enhance cancer immunotherapy
OBJECTIVES/SPECIFIC AIMS: Prostate cancer (PCa) is the most common noncutaneous malignancy in men in the United States. A significant fraction of advanced PCa treated with androgen deprivation therapy experience relentless progression to lethal metastatic castration-resistant prostate cancer (mCRPC)...
Autor principal: | Lu, Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6798891/ http://dx.doi.org/10.1017/cts.2018.127 |
Ejemplares similares
-
2456 Cutaneous lupus erythematosus patients have increased circulating myeloid-derived suppressor cells with immunosuppressive properties
por: Florez-Pollack, Stephanie, et al.
Publicado: (2018) -
2559 Role of tissue non-specific alkaline phosphatase (TNAP) in promoting the survival of acute myeloid leukemia (AML) cells within the bone marrow microenvironment
por: Bowles, Bradley, et al.
Publicado: (2018) -
2173 RNA-nanoparticles to enhance and track dendritic cell migration
por: Grippin, Adam J., et al.
Publicado: (2018) -
2018 Synaptic vesicle 2 receptors as a novel targets for
neuroendocrine cancer therapy
por: Jaskula-Sztul, Renata, et al.
Publicado: (2018) -
2325 Targeting isoform-specific PI3 kinase signaling for treatment of cutaneous T cell lymphoma
por: Raychaudhuri, Suravi, et al.
Publicado: (2018)